De novo autoimmune hepatitis after liver transplantation

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Vitamin D for your patients with chronic hepatitis C?
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients  Nazia Selzner, Maha Guindi, Eberhard.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
David D. Yuh, MD, Kimberly L. Gandy, MD, Bruce A
The role of Epstein–Barr virus in acute and chronic hepatitis
Volume 65, Issue 5, Pages (November 2016)
Hepatic CD141+IFNλ+ DC subset: One against all?
Autoimmune hepatitis – Update 2015
Acute hepatitis induced by greater celandine (Chelidonium majus)
The impact of hepatitis E in the liver transplant setting
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
The use of technetium tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection  Patrick W. Vriens, MDa, Francis G. Blankenberg,
Volume 57, Issue 1, Pages 6-8 (July 2012)
Volume 49, Issue 5, Pages (November 2008)
Immigration and viral hepatitis
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients  Nazia Selzner, Maha Guindi, Eberhard.
Regulatory T-cell directed therapies in liver diseases
Allogeneic hematopoietic cell transplant in HCV-infected patients
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results  Bruno Roche, Didier Samuel  Journal.
Living donor liver transplantation: is the hype over?
What lessons have we learned in pediatric liver transplantation?
The origin of cancer stem cells
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
The role of Epstein–Barr virus in acute and chronic hepatitis
Reply to: “DCD consensus and futility in liver transplantation”
Autoimmune hepatitis Journal of Hepatology
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Volume 69, Issue 4, Pages (October 2018)
Regulatory T-cell directed therapies in liver diseases
Hepatitis C core protein – The “core” of immune deception?
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis  William R Kessler, Oscar W Cummings, George Eckert, Naga Chalasani,
Autoimmune Hepatitis After Liver Transplantation
Volume 70, Issue 1, Pages (January 2019)
What is the long-term outcome of the liver allograft?
Grand round: Autoimmune hepatitis
Age and liver transplantation
EASL Recognition Award Recipient 2017: Prof. Giorgina Mieli-Vergani
Vitamin D for your patients with chronic hepatitis C?
Volume 59, Issue 4, Pages (October 2013)
Autoimmune pancreatitis/IgG4-associated cholangitis and primary sclerosing cholangitis – Overlapping or separate diseases?  George J.M. Webster, Stephen.
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients  Nazia Selzner, Maha Guindi, Eberhard.
Fen Huang, Chenchen Yang, Xinying Zhou, Wenhai Yu, Qiuwei Pan 
Liver stem cells—prospects for clinical use
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 56, Issue 6, Pages (June 2012)
Volume 44, Issue 4, Pages (April 2006)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Evolution of liver transplantation for hepatocellular carcinoma
Volume 63, Issue 1, Pages (July 2015)
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Statins: Old drugs as new therapy for liver diseases?
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Donor-recipient matching: Myths and realities
Chimeric mouse model of hepatitis B virus infection
Volume 44, Issue 2, Pages (February 2006)
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Outcomes in liver transplantation: Does sex matter?
Presentation transcript:

De novo autoimmune hepatitis after liver transplantation Giorgina Mieli-Vergani, Diego Vergani  Journal of Hepatology  Volume 40, Issue 1, Pages 3-7 (January 2004) DOI: 10.1016/j.jhep.2003.10.022

Fig. 1 De novo autoimmune hepatitis post liver transplant. (A) Chronic hepatitis with moderate portal and interface mononuclear cell infiltrate, including plasma cells (haematoxilyn-eosin staining); (B) reticulin staining showing bridging collapse, a lesion resulting from extensive death of hepatocytes and consequent coalescence of the supportive structure (histological pictures kindly provided by Professor Bernard Portmann). Journal of Hepatology 2004 40, 3-7DOI: (10.1016/j.jhep.2003.10.022)

Fig. 2 (A) Heart transplant from an allogeneic mouse results not only in rejection, but also in the production of antibodies and CD4 T cells directed against cardiac myosin in the recipient. (B) Transplant of allogeneic skin or of a syngeneic heart do not lead to cardiac-specific autoimmunity, indicating that this response is tissue-specific and that an allogeneic response is necessary to break tolerance to cardiac myosin. Journal of Hepatology 2004 40, 3-7DOI: (10.1016/j.jhep.2003.10.022)